A congressman from New York asked U.S. Health and Human Services Xavier Becerra during a hearing yesterday if he will use his existing authority to protect hospitals from losing eligibility for 340B drug discounts due to changes in patient mix during the COVID-19 pandemic. Becerra did not provide tremendous clarity in his response, but said that he looked forward to working with him.
U.S. Rep. Joe Morelle (D-N.Y.) raised the issue during a June 16 hearing on HHS’s fiscal 2022 budget request before the House Education and Labor Committee—an unexpected forum for 340B to come up. The program isn’t under the committee’s jurisdiction. Morelle represents Rochester, N.Y., and most of the surrounding county. His district has about 10 hospitals enrolled in 340B.
A congressman from New York asked U.S. Health and Human Services Xavier Becerra during a hearing yesterday if he will use his existing authority to protect hospitals from losing eligibility for 340B drug discounts due to changes in patient mix during the COVID-19 pandemic.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
